Catalyst
Slingshot members are tracking this event:
Celgene's(CELG) OTEZLA in Behcet’s Disease PDUFA date expected July 21, 2019
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| CELG | Community voting in process | |||||
Additional Information
FDA Approves OTEZLA® (apremilast) for the Treatment of Oral Ulcers Associated with Behçet’s Disease
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 19, 2019
Occurred Source:
https://ir.celgene.com/press-releases/press-release-details/2019/FDA-Approves-OTEZLA-apremilast-for-the-Treatment-of-Oral-Ulcers-Associated-with-Behets-Disease/default.aspx
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Otezla, Behcet's Disease
